Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Date

18 June 2020

UK launches subscription style model for antibiotics to encourage new development

In this article for the the BMJ, author Elisabeth Mahase looks into the UK's launch of a new subscription-style payment model for antibiotics, which aims to incentivise companies to invest in researching and developing new antibiotics in the face of growing antibiotic resistance.

Direct links

Read the full article

The UK has launched its subscription style payment model for antibiotics, with the first two drugs to be selected and evaluated next year. The scheme will pay pharmaceutical companies upfront for their products, based on the value they provide to the NHS,  rather than how much is used.

Our Jayasree K. Iyer is quoted in the article about the great potential such a service could have particularly if it is expanded to include a wide variety of antibiotics that are made available globally in order to reach those who need it most.

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved